New Enterprise Associates Exits Position in Arcellx, Inc. Following Gilead Merger

New Enterprise Associates 15, L.P. (NEA 15), along with its affiliated control entities and managers, filed Amendment No. 6 to Schedule 13D on April 30, 2026, reporting that they have completely exited their position in Arcellx, Inc. (ACLX). This disposition of shares was the result of a merger agreement between Arcellx and Gilead Sciences, Inc. Pursuant to the agreement, Gilead's subsidiary, Ravens Sub, Inc., completed a tender offer for all outstanding shares of Arcellx common stock on April 28, 2026. NEA 15 tendered all of its shares in exchange for $115.00 per share in cash plus one contractual contingent value right (CVR) per share. Following the consummation of the offer, Ravens Sub merged into Arcellx, making Arcellx a wholly owned subsidiary of Gilead Sciences. As of the event date, the reporting persons no longer beneficially own any shares of Arcellx common stock, effectively ceasing to be 5% owners.